SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cygnus
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: andris who wrote (8)10/16/1997 9:59:00 PM
From: Rocky Portolesi   of 19
 
There was a recent write up on Cygnus in the Globe and Mail business section in late Sept. It went on about Cygnus' newest product. I'm not sure what it is called but I know it is a patch that monitors blood glucose level. It also stated that they are awaiting FDA approval (as you probably know) and the patch, if approved, would be of great convenience to all diabetics who normally would have to prick a finger in order to produce a blood sample for measuring. The analyst projected this stock to be in the U.S $35.00 range within 12 months. I usually like to back my postings up with facts but unfortunately I cannot in this case. Besides this may be old news to you anyway.

Good Luck....
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News